Join to access to all OVN content. Join for Free

Results for 'KOL Relationships'

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Tom Caravela

Promotability: How to Land Your Next Promotion

May 5^th • 10 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3^rd • 1 min read

Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Nov 20^th • 12 mins read

Dean Bottino, Rachael Liu, Hojjat Bazzazi, Karthik Venkatakrishnan

Quantitative Translation in Immuno-Oncology Research and Development

Jul 9^th • 3 mins read

Envision Pharma Group

Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?

May 9^th • 5 mins read

Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Aug 2^nd • 3 mins read

Mohamed Elmeliegy PhD, Derek Z. Yang BS, Engie Salama PharmD, Kourosh Parivar MPharm, Diane D. Wang PhD

Discordance Between Child-Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds

Jul 20^th • 18 mins read

Kirill Peskov, Ivan Azarov, Lulu Chu, Veronika Voronova, Yuri Kosinsky, Gabriel Helmlinger

Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology

Apr 30^th • 12 mins read

Related Topics

See More Topics

Voices of Oncology

Envision Pharma Group